N. Anthony Coles - Aug 17, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
By: Beverly Dubs as attorney-in-fact For: N. Anthony Coles
Stock symbol
REGN
Transactions as of
Aug 17, 2021
Transactions value $
-$1,827,180
Form type
4
Date filed
8/19/2021, 04:04 PM
Previous filing
Aug 16, 2021
Next filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $311K +900 +99.78% $345.47 1.8K Aug 17, 2021 Direct F1
transaction REGN Common Stock Sale -$585K -900 -49.94% $650.00 902 Aug 17, 2021 Direct F1
transaction REGN Common Stock Options Exercise $1.76M +5.1K +565.41% $345.47 6K Aug 18, 2021 Direct F1
transaction REGN Common Stock Sale -$3.32M -5.1K -84.97% $650.00 902 Aug 18, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -900 -8.15% $0.00 10.1K Aug 17, 2021 Common Stock 900 $345.47 Direct F1, F2
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.1K -50.3% $0.00 5.04K Aug 18, 2021 Common Stock 5.1K $345.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.